Star Power 2026: Q&A with Lila Dabill, PhD

Published on August 21, 2026

Early-career and in-training members get their chances to shine brightly at the Rising Star Power Talks that take place at ENDO each year. Endocrine News caught up with this year’s Basic Science winner, Lila Dabill, a PhD student at Washington University in St. Louis, Mo., to learn more about her research, future plans, the impact […]

The post Star Power 2026: Q&A with Lila Dabill, PhD appeared first on Endocrine News.

Continue reading on website
Other news

EDC Exposure May Be Linked to High Blood Pressure During Pregnancy

August 20, 2026
Phthalates, which are chemicals found in plastics, personal care products, and hundreds of other consumer goods, may contribute to high blood pressure in pregnant women, according to a study published in the Journal of the Endocrine Society. Hypertensive disorders of pregnancy such as preeclampsia are a leading cause of maternal mortality in the United States. Higher […]The post EDC Exposure May B

Pharma Friday – August 21, 2026

August 21, 2026
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia On August 18, Amylyx Pharmaceuticals, Inc., announced positive topline results from LUCIDITY, a 78-participant, multicenter, randomized, double-blind, placebo